Literature DB >> 6603302

HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes.

F Pandolfi, G Semenzato, G de Rossi, I Quinti, C Guglielmi, A Pezzutto, M Lopez, G Tonietti, L Fontana, T Abo, F Aiuti.   

Abstract

Among 12 cases of chronic T lymphoproliferative disorders we observed, six patients showed an expansion of mononuclear cells with azurophilic granules usually referred to as large granular lymphocytes or LGL. Cells obtained from five patients with these abnormal LGL proliferations were studied with several surface markers including their reactivity with the HNK-1 monoclonal antibody reported to be specific for LGL. Cells in four out of five cases were HNK-1 positive. Whereas normal LGL have been reported to be unreactive with several T cell markers, three cases showed the co-existence of HNK-1 and surface markers expressed by T cells. Two cases were characterized by the proliferation of OKT8 cells. Cells from one patient were HNK-1 positive but did not express T or monocytic antigens. These cells were apparently not completely mature since alpha-naphthyl acetate acid esterase activity was negative. Cells from the remaining case were HNK-1 negative and positive for T and monocytic antigens. An increase of OKT-10 cells was observed in only one patient. Our data indicate that proliferations of LGL represent a remarkable proportion of the rare cases of sheep erythrocyte rosetting chronic lymphocytic leukaemias or lymphomas. Besides the morphology of LGL, the rosetting ability and the negativity for peroxidase, cells from these cases showed a vast heterogeneity of other structural and functional markers, possibly reflecting different stages in the maturation of these cells. The HNK-1 monoclonal antibody proved to be an important marker in the identification of these cases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603302      PMCID: PMC1536035     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  Characterization of natural killer (NK) cells and killer (K) cells in human blood: discrimination between NK and K cell activities.

Authors:  R L Bolhuis; H R Schuit; A M Nooyen; C P Ronteltap
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

Review 3.  Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974.

Authors: 
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

4.  Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TG lymphocytes.

Authors:  M Ferrarini; A Cadoni; A T Franzi; C Ghigliotti; A Leprini; A Zicca; C E Grossi
Journal:  Eur J Immunol       Date:  1980-07       Impact factor: 5.532

5.  Cytochemical study of thymocytes and T lymphocytes.

Authors:  G Basso; M G Cocito; G Semenzato; A Pezzutto; L Zanesco
Journal:  Br J Haematol       Date:  1980-04       Impact factor: 6.998

6.  Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity.

Authors:  F Pandolfi; D M Strong; R B Slease; M L Smith; J R Ortaldo; R B Herberman
Journal:  Blood       Date:  1980-10       Impact factor: 22.113

7.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

Review 8.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

9.  Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.

Authors:  B F Haynes; R S Metzgar; J D Minna; P A Bunn
Journal:  N Engl J Med       Date:  1981-05-28       Impact factor: 91.245

10.  Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG.

Authors:  C E Grossi; S R Webb; A Zicca; P M Lydyard; L Moretta; M C Mingari; M D Cooper
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  7 in total

1.  Immunophenotype analysis of malignant histiocytosis of the intestine.

Authors:  D M Salter; A S Krajewski; A E Dewar
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

Review 2.  The human NK cell--a short over-view and an hypothesis on NK recognition.

Authors:  M Jondal
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

Review 3.  Cytochemistry of lymphoid cells: a review of findings in the normal and leukaemic state.

Authors:  A D Crockard
Journal:  Histochem J       Date:  1984-10

4.  Classification of patients with T-cell chronic lymphocytic leukemia and expansions of granular lymphocytes: heterogeneity of Italian cases by a multiparameter analysis.

Authors:  F Pandolfi; F Mandelli; G Semenzato; A Ranucci; F Aiuti
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

5.  A lymphoproliferative disorder of granular lymphocytes with a novel phenotype and suppressor function.

Authors:  A Landay; M C Poon; L T Clement; C E Grossi
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

6.  T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneous.

Authors:  F Miedema; F G Terpstra; J W Smit; J P van der Veen; C J Melief
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

7.  Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytes.

Authors:  R Zambello; T Chisesi; C Agostini; L Trentin; M Masciarelli; G Gasparotto; M Vespignani; G Casorati; R Foa; G Semenzato
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.